Skip to main content
NeuronFeed

NVision · Series B

Quantum-enhanced MRI that images disease metabolism in real time

Amount

$55M

Round

Series B

Valuation

Announced

May 2026

Investors

Lead investor

Abbott

Participating investors

📎 Source